Finance

Beta
Lists
ELDN:NASDAQ
Eledon Pharmaceuticals Inc
$3.85
-6.78%
(-0.28) 1D
$3.93
+2.08% (+0.080)
After hours
Closed: Jul 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELDN...
Open
$4.11
High
$4.12
Low
$3.80
Mkt. cap
297.17M
Avg. vol.
1.60M
Volume
1.39M
52-wk high
$4.60
52-wk low
$1.35
EPS
-$0.83
Beta
0.95
Shares outstanding
77.19M
No. of employees
33
Open
$4.11
High
$4.12
Low
$3.80
Mkt. cap
297.17M
Avg. vol.
1.60M
Volume
1.39M
52-wk high
$4.60
52-wk low
$1.35
EPS
-$0.83
Beta
0.95
Shares outstanding
77.19M
No. of employees
33
News stories
From sources across the web
About Eledon Pharmaceuticals Inc
CEO-
Employees33
Founded2004
HeadquartersIrvine, California, United States
SectorBiotechnology
Websiteeledon.com
Analyst ratings
Based on 3 analysts giving stock ratings to ELDN in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ELDN in the last 3 months.
Highest
Current $3.85
$10.00 (+159.74%)
Average
$8.67 (+125.19%)
Lowest
$8.00 (+107.79%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$8.00
+107.8%
06/27/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
$10.00
+159.7%
06/23/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
$8.00
+107.8%
06/22/2026
Vamil Divan
Guggenheim
Buy
Maintained
$8.00
+107.8%
03/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.28M
14.97M
17.49M
17.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.46M
4.10M
3.99M
3.98M
Operating expense
24.73M
19.07M
21.48M
21.18M
Total operating expenses
24.73M
19.07M
21.48M
21.18M
Operating income
-24.73M
-19.07M
-21.48M
-21.18M
Other non operating income
13.52M
1.61M
11.07M
-17.84M
EBT including unusual items
-11.22M
-17.46M
-10.41M
-39.02M
EBT excluding unusual items
-11.22M
-17.46M
-10.41M
-39.02M
Income tax expense
-
-
35.00K
-
Effective tax rate
-
-
-0.34%
-
Other operating expenses
-
-
-
-
Net income
-11.22M
-17.46M
-10.45M
-39.02M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.21
-0.10
-0.33
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer